LeonaBio Inc (LONA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$7.56-1.82%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · LONA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 33.5 | 17.5 | 70.7 | 93.8 | 61.5 | 42.8 | 13.3 |
| Operating Income | (122.1) | (102.3) | (100.9) | (125.5) | (104.0) | (64.0) | (20.0) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | — | — | — | 0.0 | 0.4 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | 0.3 | (1.3) |
| EBT, Incl. Unusual Items | — | — | — | — | — | — | (20.0) |
| Net Income | |||||||
| Net Income | (141.8) | (105.6) | (96.9) | (117.7) | (95.6) | (54.9) | (20.0) |
| Per Share | |||||||
| Basic EPS | (5.98) | (24.70) | (2.52) | (3.09) | (2.53) | (1.49) | — |
| Diluted EPS | (5.98) | (24.70) | (2.52) | (3.09) | (2.53) | (1.49) | — |
| Basic Weighted Avg Shares | 23.7 | 4.3 | 38.5 | 38.0 | 37.7 | 36.9 | — |
| Diluted Weighted Avg Shares | 23.7 | 4.3 | 38.5 | 38.0 | 37.7 | 36.9 | — |
| Supplemental | |||||||
| EBIT | (122.1) | (102.3) | (100.9) | (125.5) | (104.0) | (64.0) | (20.0) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.